Tags

Type your tag names separated by a space and hit enter

Laser treatment of erythema and telangiectasia associated with rosacea.
Lasers Med Sci. 2002; 17(1):26-33.LM

Abstract

The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea.

Authors+Show Affiliations

Department of Dermatology, The University Hospital of Wales, Heath Park, Cardiff, UK.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11845365

Citation

Clark, S M., et al. "Laser Treatment of Erythema and Telangiectasia Associated With Rosacea." Lasers in Medical Science, vol. 17, no. 1, 2002, pp. 26-33.
Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci. 2002;17(1):26-33.
Clark, S. M., Lanigan, S. W., & Marks, R. (2002). Laser treatment of erythema and telangiectasia associated with rosacea. Lasers in Medical Science, 17(1), 26-33.
Clark SM, Lanigan SW, Marks R. Laser Treatment of Erythema and Telangiectasia Associated With Rosacea. Lasers Med Sci. 2002;17(1):26-33. PubMed PMID: 11845365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laser treatment of erythema and telangiectasia associated with rosacea. AU - Clark,S M, AU - Lanigan,S W, AU - Marks,R, PY - 2002/2/15/pubmed PY - 2002/4/5/medline PY - 2002/2/15/entrez SP - 26 EP - 33 JF - Lasers in medical science JO - Lasers Med Sci VL - 17 IS - 1 N2 - The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea. SN - 0268-8921 UR - https://www.unboundmedicine.com/medline/citation/11845365/Laser_treatment_of_erythema_and_telangiectasia_associated_with_rosacea_ L2 - https://dx.doi.org/10.1007/s10103-002-8263-8 DB - PRIME DP - Unbound Medicine ER -